Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prolactinoma × Standard of Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 59 Neoplasms 56 Prostatic Neoplasms 39 Colorectal Neoplasms 35 Lung Neoplasms 33 Carcinoma, Non-Small-Cell Lung 23 Neoplasm Metastasis 18 Hematologic Neoplasms 18 Head and Neck Neoplasms 18 Pancreatic Neoplasms 16 Urinary Bladder Neoplasms 14 Ovarian Neoplasms 11 Multiple Myeloma 11 Motor Activity 11 Leukemia, Myeloid, Acute 11 Squamous Cell Carcinoma of Head and Neck 10 Stomach Neoplasms 9 Hematopoietic and Lymphatic System Neoplasm 8 Anxiety Disorders 8 Triple Negative Breast Neoplasms 7 Melanoma 7 Glioma 7 Glioblastoma 7 Gastrointestinal Neoplasms 7 Colonic Neoplasms 7 Carcinoma, Renal Cell 7 COVID-19 7 Uterine Cervical Neoplasms 6 Sarcoma 6 Recurrence 6

Interventions

Cabergoline 4 ropinirole 1 pasireotide 1 Temozolomide 1 Surgical Procedures, Operative 1 Standard of Care 1 Microarray Analysis 1 Early Intervention, Educational 1 Dopamine Agonists 1 Dexamethasone 1 DNA Methylation 1 Clomiphene 1 Calcium Dobesilate 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04107480 2020-07-20

PRolaCT - Three Prolactinoma RCTs

Leiden University Medical Center

Phase 4 Recruiting

Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡